GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)

Completed

Conditions studied: GM1 Gangliosidosis, Sandhoff Disease, Tay-Sachs Disease

In brief

The study aims to characterize prospectively longitudinal progression of neurological domains in GM1 and GM2 Gangliosidosis patients with high-quality standards (GCP compliant).

Key facts

Study ID
NCT05109793
Run by
Azafaros B.V.
People needed
31
Starts
2022-02-22
Expected to finish
2025-09-16
Last updated by the study team
2025-09-29

Who can join

Age: 2 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.